Startseite Reference ranges for sphingosine-1-phosphate in neonates
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Reference ranges for sphingosine-1-phosphate in neonates

  • Chinedu Ulrich Ebenebe EMAIL logo , Mirjam von Lucadou , Eileen Moritz , Edzard Schwedhelm , Guenter Daum , Dominique Singer , Phillip Deindl und Martin Sebastian Winkler
Veröffentlicht/Copyright: 15. April 2021

Abstract

Objectives

Sphingosine-1-phosphate (S1P) is a signalling lipid involved in embryonic development, physiological homeostasis, and pathogenic processes in multiple organ systems. Disturbance of S1P homeostasis has been associated with various human diseases in which the immune response and vascular integrity are severely compromised. Up-to-date, no study has analyzed S1P levels in neonates. The objective of this study was to determine S1P serum concentrations in neonates and establish S1P reference ranges.

Methods

S1P levels in the umbilical cord blood of 460 term and preterm neonates were compared to a previously described cohort of healthy adult blood donors. S1P levels were further correlated with demographic characteristics, cellular sources of S1P, and inflammatory markers.

Results

The median S1P serum level in neonates was 1.70 μmol/L (IQR 1.41–1.97 μmol/L) and significantly higher than normal values reported in adults. S1P levels correlated positively with the number of red blood cells (p<0.001) and negatively with neutrophil precursors (p=0.028).

Conclusions

Elevated S1P levels in neonates compared to adults possibly result from higher S1P content in its cellular sources due to the essential role of S1P during embryogenesis. Generated S1P ranges may be used as reference ranges for future studies in neonates.


Corresponding author: Chinedu Ulrich Ebenebe, MD, MBA, Department of Pediatrics, Division of Neonatology and Pediatric Intensive Care, University Medical Center Hamburg-Eppendorf, Martinistr. 52, 20246 Hamburg, Germany, Phone: +40 40 7410 20421, Fax: +40 40 7410 20443, E-mail:

  1. Research funding: None declared.

  2. Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  3. Competing interests: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: The study protocol was approved by the Ethics Committee of the local medical chamber of Hamburg.

References

1. Hla, T. Signaling and biological actions of sphingosine 1-phosphate. Pharmacol Res 2003;47:401–7. https://doi.org/10.1016/s1043-6618(03)00046-x.Suche in Google Scholar PubMed

2. Matloubian, M, Lo, CG, Cinamon, G, Lesneski, MJ, Xu, Y, Brinkmann, V, et al.. Lymphocyte egress from thymus and peripheral lymphoid organs is dependent on S1P receptor 1. Nature 2004;427:355–60. https://doi.org/10.1038/nature02284.Suche in Google Scholar PubMed

3. Winkler, MS, Nierhaus, A, Holzmann, M, Mudersbach, E, Bauer, A, Robbe, L, et al.. Decreased serum concentrations of sphingosine-1-phosphate in sepsis. Crit Care 2015;19:372. https://doi.org/10.1186/s13054-015-1089-0.Suche in Google Scholar PubMed PubMed Central

4. Proia, RL, Hla, T. Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy. J Clin Invest 2015;125:1379–87. https://doi.org/10.1172/jci76369.Suche in Google Scholar

5. Rotshenker-Olshinka, K, Shinwell, ES, Juster-Reicher, A, Rosin, I, Flidel-Rimon, O. Comparison of hematologic indices and markers of infection in umbilical cord and neonatal blood. J Matern Fetal Neonatal Med 2014;27:625–8. https://doi.org/10.3109/14767058.2013.825597.Suche in Google Scholar PubMed

6. Moritz, E, Wegner, D, Gross, S, Bahls, M, Dorr, M, Felix, SB, et al.. Data on subgroup specific baseline characteristics and serum sphingosine-1-phosphate concentrations in the Study of Health in Pomerania. Data Brief 2017;12:46–50. https://doi.org/10.1016/j.dib.2017.03.019.Suche in Google Scholar PubMed PubMed Central

7. Hanel, P, Andreani, P, Graler, MH. Erythrocytes store and release sphingosine 1-phosphate in blood. Faseb J 2007;21:1202–9. https://doi.org/10.1096/fj.06-7433com.Suche in Google Scholar PubMed

8. Poppe, A, Moritz, E, Geffken, M, Schreiber, J, Greiwe, G, Amschler, K, et al.. Analyses of sphingosine-1-phosphate in the context of transfusion: how much is in stored blood products and in patient blood? Transfusion 2019;59:3071–6. https://doi.org/10.1111/trf.15494.Suche in Google Scholar PubMed

9. Venkataraman, K, Lee, YM, Michaud, J, Thangada, S, Ai, Y, Bonkovsky, HL, et al.. Vascular endothelium as a contributor of plasma sphingosine 1-phosphate. Circ Res 2008;102:669–76. https://doi.org/10.1161/circresaha.107.165845.Suche in Google Scholar PubMed PubMed Central

10. Weinberg, PD, Ross Ethier, C. Twenty-fold difference in hemodynamic wall shear stress between murine and human aortas. J Biomech 2007;40:1594–8. https://doi.org/10.1016/j.jbiomech.2006.07.020.Suche in Google Scholar PubMed

11. Kono, M, Mi, Y, Liu, Y, Sasaki, T, Allende, ML, Wu, YP, et al.. The sphingosine-1-phosphate receptors S1P1, S1P2, and S1P3 function coordinately during embryonic angiogenesis. J Biol Chem 2004;279:29367–73. https://doi.org/10.1074/jbc.m403937200.Suche in Google Scholar


Supplementary Material

The online version of this article offers supplementary material (https://doi.org/10.1515/jpm-2020-0536).


Received: 2020-11-21
Accepted: 2021-03-31
Published Online: 2021-04-15
Published in Print: 2021-09-27

© 2021 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Editorial
  3. Introduction to the cesarean section articles
  4. Highlight Section: Cesarean Section
  5. Three kinds of caesarean sections: the foetal/neonatal perspective
  6. The neonatal respiratory morbidity associated with early term caesarean section – an emerging pandemic
  7. Vaginal birth after cesarean (VBAC): fear it or dare it? An evaluation of potential risk factors
  8. Nationwide implementation of a decision aid on vaginal birth after cesarean: a before and after cohort study
  9. Induction of labor at 39 weeks and risk of cesarean delivery among obese women: a retrospective propensity score matched study
  10. Cervical ripening after cesarean section: a prospective dual center study comparing a mechanical osmotic dilator vs. prostaglandin E2
  11. An evidence-based cesarean section suggested for universal use
  12. Online survey on uterotomy closure techniques in caesarean section
  13. Analysis of cesarean section rates in two German hospitals applying the 10-Group Classification System
  14. Reviews
  15. Pregnancy in incarcerated women: need for national legislation to standardize care
  16. Imaging diagnosis and legal implications of brain injury in survivors following single intrauterine fetal demise from monochorionic twins – a review of the literature
  17. Mini Review
  18. Professionally responsible management of the ethical and social challenges of antenatal screening and diagnosis of β-thalassemia in a high-risk population
  19. Opinion Paper
  20. Teaching and training the total percutaneous fetoscopic myelomeningocele repair
  21. Corner of Academy
  22. Chronic hypertension in pregnancy: synthesis of influential guidelines
  23. Original Articles
  24. The effects of pre-pregnancy obesity and gestational weight gain on maternal lipid profiles, fatty acids and insulin resistance
  25. Determination of organic pollutants in meconium and its relationship with fetal growth. Case control study in Northwestern Spain
  26. Betamethasone as a potential treatment for preterm birth associated with sterile intra-amniotic inflammation: a murine study
  27. Diagnostic accuracy of modified Hadlock formula for fetal macrosomia in women with gestational diabetes and pregnancy weight gain above recommended
  28. Vasa previa: when antenatal diagnosis can change fetal prognosis
  29. Mode of delivery and adverse short- and long-term outcomes in vertex-presenting very preterm born infants: a European population-based prospective cohort study
  30. Short Communication
  31. Reference ranges for sphingosine-1-phosphate in neonates
Heruntergeladen am 1.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpm-2020-0536/html
Button zum nach oben scrollen